SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-06-166577
Filing Date
2006-08-09
Accepted
2006-08-09 06:27:32
Documents
7
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d10q.htm 10-Q 521268
2 COLLABORATION AGREEMENT dex1041.htm EX-10.41 405803
3 COLLABORATION SECURITY AGREEMENT dex1042.htm EX-10.42 77261
4 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 7776
5 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 7827
6 SECTION 906 CEO & CFO CERTIFICATION dex321.htm EX-32.1 3904
7 GRAPHIC g57841img1.jpg GRAPHIC 6141
  Complete submission text file 0001193125-06-166577.txt   1033961
Mailing Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 345 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650.635.1100
Monogram Biosciences, Inc. (Filer) CIK: 0001094961 (see all company filings)

IRS No.: 943234479 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30369 | Film No.: 061015008
SIC: 2835 In Vitro & In Vivo Diagnostic Substances